DIRS.INFO top alerts submit data jurnalism about API
login
Top related persons:
Megan Jelinger - 2 Dawn - 1 Michael Sen - 1 Danish drugmaker - 1 Neil Unmack - 1 Oliver Taslic - 1 Dawn Heidlebaugh - 1 ” - 1
Top related locs:
Findlay , Ohio U.S Germany Fresenius Vamed Danish Ohio Novo
Top related orgs:
REUTERS - 2 Novo Nordisk - 2 Thomson - 2 Denmark’s Novo Nordisk - 1 Fresenius - 1 Novo - 1 U.S . Food - 1 Drug Administration - 1

Search resuls for: "Dawn Heidlebaugh"


2 mentions found


☆ Obesity revolution gorges on dialysis maker
  + stars: | 2023-10-11 | by ( Aimee Donnellan | ) www.reuters.com   time to read: +3 min
REUTERS/Megan Jelinger Acquire Licensing RightsLONDON, Oct 11 (Reuters Breakingviews) - Kidney dialysis kit-makers look set to be the latest victim of the obesity drug boom. On Wednesday, shares in Germany-listed Fresenius Medical Care (FMEG.DE) fell 20% after a medical trial showed a Novo Nordisk (NOVOb.CO) drug can reduce the risk of kidney failure. Diabetes and obesity drugs are showing their fringe benefits. In a recent drug trial, Wegovy, an obesity remedy made by Denmark’s Novo Nordisk, reduced the incidence of serious cardiovascular events like strokes and heart attacks by 20% in overweight patients. The collapse in Fresenius Medical Care’s share price looks appropriate.
Persons: Dawn, Megan Jelinger, Michael Sen, Danish drugmaker, Neil Unmack, Oliver Taslic Organizations: REUTERS, Reuters, Novo Nordisk, Denmark’s Novo Nordisk, Fresenius, Thomson Locations: Findlay , Ohio, U.S, Germany, Fresenius, Vamed, Danish
☆ Wegovy, other weight-loss drugs scrutinized over reports of suicidal thoughts
  + stars: | 2023-09-28 | by ( Robin Respaut Chad Terhune | Robin Respaut | Chad Terhune | ) www.reuters.com   time to read: +14 min
Accounts of suicidal thoughts linked to this class of drugs are drawing increasing scrutiny, including an investigation by European regulators announced in July. More than half of the narrative summaries describe suicidal thoughts appearing shortly after the person started the medicine or increased the dose. Wegovy’s U.S. prescribing label, produced with FDA approval, says suicidal thoughts or attempts have been reported in clinical trials for other weight-loss medicines. Sanofi's Acomplia, which never won U.S. approval, was withdrawn in Europe in 2008 after being linked to suicidal thoughts. She said she has not experienced any suicidal thoughts on that drug.
Persons: Dawn Heidlebaugh, Megan Jelinger, ”, Heidlebaugh, Eli Lilly, Thomas J, Moore, aren't, It’s, Novo, Dr, Erick Turner, Turner, Novo’s, drugmakers, Sanofi's, Sanofi, Contrave, John Amos, Lilly, Reuters weren’t, Lisa Wood, ” Wood, Sarah Sobol, you’re, Sobol, ’ ” Katherine, Jayson Chesnutt, Chesnutt, Robin Respaut, Chad Terhune, Maggie Fick, Ludwig Burger, Michele Gershberg, Brian Thevenot Organizations: REUTERS, Novo, U.S . Food, Drug Administration, Reuters, FDA, Johns Hopkins Bloomberg School of Public Health, Oregon Health & Science University, Novo Nordisk, U.S ., European Union, European Medicines Agency, U.S, Currax Pharmaceuticals, Vivus, Facebook, Thomson Locations: Findlay , Ohio, U.S, Ohio, Novo, Canada, Europe, Carolina, Buffalo , New York, North Carolina, Indiana
0 next >>
Total: 2